This is a momentous opportunity. I mean, the geek in me is amazed that we – nobody would have thought. I think even if we looked back on the initial discovery of the virus, less than a year later we would approve and then distribute a vaccine. I think it’s just evidence of the decades of science, technology, and research that went into developing this vaccine. I think it is a testament to the work of regulators working together internationally. It is a will for our team that has invested an incredible amount of time, energy and resources on it. And I think it’s an extraordinary day for Canada. When we do an authorization, it means we’ve looked at it and the benefits outweigh the potential risks. But it’s still a drug. It’s still a vaccine and there are potential risks, even if they’re rare. So it is important that we continue to monitor it. So I would tell the Canadians, you know, we authorized it. If it is your turn to get the vaccine, you should definitely be comfortable getting the vaccine. However, we need to continue to monitor it like any other product as the research is obviously done in clinical trials. They are carried out in smaller groups of people under ideal conditions. And we need to get information from the vaccine when it comes out and is used in higher numbers of people, not just in Canada but around the world.
Comments are closed.